Literature DB >> 16958462

Managing bone loss in revision total hip arthroplasty: the acetabulum.

David A L O'Brien1, Cecil H Rorabeck.   

Abstract

Osteolysis is the greatest threat to the viability of modern acetabular implants. The etiology and natural history of osteolysis remain unknown. Patients with cementless implants who have osteolysis are challenging to treat. There are no standards for follow-up methods or frequency, and there is little evidence to support timing of the decision to begin treatment in these patients. The natural history of proposed treatment options is also unknown. Reconstruction of the acetabulum in the presence of bone loss is difficult. Classifications have been developed to guide management. Multiple options exist for revision acetabular surgery, and it is important to understand the rationale and data in support of these options. A review of the literature was undertaken and algorithms were developed to help address acetabular bone loss in patients undergoing revision surgery.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16958462

Source DB:  PubMed          Journal:  Instr Course Lect        ISSN: 0065-6895


  3 in total

1.  Limitations of conventional radiographs in the assessment of acetabular defects following total hip arthroplasty.

Authors:  Oleg Safir; Cliff Lin; Yona Kosashvili; Ian P Mayne; Allan E Gross; David Backstein
Journal:  Can J Surg       Date:  2012-12       Impact factor: 2.089

2.  Cup-cage construct for massive acetabular defect in revision hip arthroplasty- A case series with medium to long-term follow-up.

Authors:  Dan Arvinte; Manish Kiran; Manoj Sood
Journal:  J Clin Orthop Trauma       Date:  2019-04-25

Review 3.  The Diagnosis and Treatment of Acetabular Bone Loss in Revision Hip Arthroplasty: An International Consensus Symposium.

Authors:  Peter K Sculco; Timothy Wright; Michael-Alexander Malahias; Alexander Gu; Mathias Bostrom; Fares Haddad; Seth Jerabek; Michael Bolognesi; Thomas Fehring; Alejandro Gonzalez DellaValle; William Jiranek; William Walter; Wayne Paprosky; Donald Garbuz; Thomas Sculco
Journal:  HSS J       Date:  2021-09-28
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.